Table 1.

Demographic and clinical information

	bvFTD (n = 18)	AD (n = 12)	CTRL (n = 15)	P	Post hoc
Sex (M:F)	13:5	7:5	5:10	0.080*
Age	63.4 ± 9.8	65.5 ± 7.3	65.7 ± 4.7	0.636
Education (yrs)	11.7 ± 3.0	13.6 ± 3.6	13.9 ± 2.7	0.066#
Disease duration (yrs)	8.3 ± 5.9	5.1 ± 3.1	−	0.261†
ACE-III (/100)	82.0 ± 9.9	65.9 ± 12.6	94.8 ± 3.0	< 0.001	Patients < Controls; AD < bvFTD
CDR-FTLD Sob	5.3 ± 4.6	5.0 ± 3.5	0.2 ± 0.2	< 0.001	Patients < Controls

Demographic and clinical information for behavioral-variant frontotemporal dementia (bvFTD), Alzheimer’s disease (AD) and controls (CTRL). Values are mean ± standard deviation. ^*χ2 test, †Mann–Whitney, #Kruskal–Wallis test. ACE-III = Addenbrooke’s Cognitive Examination—Third edition; CDR-FTLD SoB = Frontotemporal Lobar Degeneration-Modified Clinical Dementia Rating Scale Sums of Boxes (CDR-FTLD SoB). Missing Scores: Education (2 AD); Disease duration (4 AD); ACE-III (1 AD), CDR-FTLD SoB (1 AD, 3 CTRL).